Jenapharm Gmbh

Jenapharm Gmbh & Co. Kg

Jens Schroder

Michael Oettel

Peter Droescher

Bernd Menzenbach

Gunter Kaufmann

Wolfgang Romer

Kurt Ponsold

Bernd Undeutsch

Sigfrid Schwarz

Rolf-Dieter Hesch

Novel substituted steroid compounds are disclosed which are more effective than known radical-trapping agents in methods of prophylaxis and therapy of radical-mediated cell damage and of treatment of diseases due to radical-mediated cell damage. The novel substituted steroid compounds can be made from steroids having an estrane, androstane, pregnane or cholestane basic skeleton and have a radical-attracting aromatic substituent of the general formula --(CH.sub.2).sub.n X, or .dbd.CH--(CH.sub.2).sub.m X at the 17 or 6 position of the steroid nucleus, wherein X=Y, OY, SY, SeY or NHY; n=0 to 5; m=n-1 and Y is a phenyl group having five substituents A, B, C, D and E, wherein A to E is independently H, alkyl, Oalkyl, Oacyl, OH, or one of the substituents B, C or D is NR.sub.2 wherein R=alkyl and each of the other substituents is hydrogen. Pharmaceutical compositions containing the novel substituted steroid compounds and methods of making them are also part of the invention.

Steroids with radical-attracting aromatic substituents, process for the

Androgens and anabolic agents

Growing community of inventors

Jena, Germany

Jens Schroder